Non-V600 BRAF mutations recurrently found in lung cancer predict sensitivity to the combination of Trametinib and Dabrafenib.

Non-V600 BRAF mutations recurrently found in lung cancer predict sensitivity to the combination of Trametinib and Dabrafenib.

Item
http://www.wikidata.org/entity/Q41694346
Non-V600 BRAF Mutations Define a Clinically Distinct Molecular Subtype of Metastatic Colorectal Cancer.Expanded molecular interrogation for potential actionable targets in non-squamous non-small cell lung cancer.Combination of immunotherapy with targeted therapies in advanced non-small cell lung cancer (NSCLC).Therapeutic strategies and genetic profile comparisons in small cell carcinoma and large cell neuroendocrine carcinoma of the lung using next-generation sequencing.Receptor tyrosine kinases and downstream pathways as druggable targets for cancer treatment: the current arsenal of inhibitors.Type II RAF inhibitor causes superior ERK pathway suppression compared to type I RAF inhibitor in cells expressing different BRAF mutant types recurrently found in lung cancer.Dabrafenib in combination with trametinib in the treatment of patients with BRAF V600-positive advanced or metastatic non-small cell lung cancer: clinical evidence and experience.Pan-RAF and MEK vertical inhibition enhances therapeutic response in non-V600 BRAF mutant cells.Current and Future Molecular Testing in NSCLC, What Can We Expect from New Sequencing Technologies?Efficacy of vemurafenib in a heavy smoker with BRAF-mutated lung adenocarcinoma: A case report and literature reviewFrequency of actionable alterations in epidermal growth factor receptor wild type non-small cell lung cancer: experience of the Wide Catchment Area of Romagna (AVR)
P2860

Non-V600 BRAF mutations recurrently found in lung cancer predict sensitivity to the combination of Trametinib and Dabrafenib.

Item
http://www.wikidata.org/entity/Q41694346
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Non-V600 BRAF mutations recurr ...... of Trametinib and Dabrafenib.
@en
type
label
Non-V600 BRAF mutations recurr ...... of Trametinib and Dabrafenib.
@en
prefLabel
Non-V600 BRAF mutations recurr ...... of Trametinib and Dabrafenib.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P932
P356
P1433
P1476
Non-V600 BRAF mutations recurr ...... n of Trametinib and Dabrafenib
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P932